Prof. Dr. Dominik Fleischmann

08/2021

Prof. Dr. Dominik Fleischmann

Accurate, reproducible, and standardized assessment of treatment response is of fundamental importance in oncology. A powerful yet easy to use and integrated software such as mint Lesion™ may be exactly what it takes to migrate such a capability from the world of clinical trials to everyday practice of Radiology and Oncology.

Related Resources

RSNA 2015

12/2015

This year's RSNA 2015 in Chicago was the highlight of our trade fair activities and exceeded our expectations by far. In addition to the structured…

Hands-on with mint Lesion™ at ESOI Autumn Workshop in Munich

11/2015

It was a great pleasure to participate at the Autumn Workshop of European Society of Oncological Imaging (ESOI), that took place in Munich from…

James, please!

07/2015

Intelligent, context driven assistance systems guide users in a standardized way through the reading process and generate all relevant information on…

Name	Purpose	Lifetime	Type	Provider
CookieConsent	Saves your consent to using cookies.	1 year	HTML	Website
fe_typo_user	Assigns your browser to a session on the server.	session	HTTP	Website

Name	Purpose	Lifetime	Type	Provider
_pk_id	Used to store a few details about the user such as the unique visitor ID.	13 months	HTML	Matomo
_pk_ref	Used to store the attribution information, the referrer initially used to visit the website.	6 months	HTML	Matomo
_pk_ses	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_cvar	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_hsr	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo

The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.